The Delhi High Court on Thursday asked the AAP government to take action against illegal and unauthorised pathological laboratories in the national capital in accordance with the guidelines issued by the Supreme Court.
"Take action as directed by the Supreme Court against some of the illegal labs," a bench of Chief Justice D N Patel and Justice Jasmeet Singh said to the Delhi government.
The high court asked the Delhi government to place before it on the next date of hearing -- April 7 -- the action taken by it against illegal and unauthorised labs.
The oral direction from the bench came during hearing of a plea seeking urgent implementation of the Delhi government's Health Bill, 2019, or the Delhi Clinical Establishment Act, 2010.
The plea by consumer rights activist Bejon Kumar Misra has alleged that unauthorised pathological laboratories were being operated in the national capital without any checks and balances.
Advocate Shashank Deo Sudhi, appearing for Misra, told the court that the Delhi government on each date of hearing seeks more time to implement the Bill or the 2010 Act, but till date nothing has been done and the citizens need to know which labs in the national capital are authorised and which are illegal.
Sudhi said some action has to be taken against the illegal labs in accordance with the guidelines issued by the apex court.
He also told the bench that the high court in 2018 had directed the Delhi government to take appropriate steps in accordance with the guidelines issued by the Supreme Court to contain illegal and unauthorised labs, but no steps have been taken by the authorities.
Misra has alleged that the Delhi government "has not made any efforts towards the regulation of illegal pathological laboratories/diagnostic centres being run illegally, which do not meet the norms and without having qualified pathologists".
He has claimed in his plea that according to the National Accreditation Board for Laboratories and Calibration (NABL), there are 1,000 diagnostic laboratories, out of which only 10 per cent are NABL accredited.
Misra had moved the high court in 2018 seeking closure of the unauthorised pathological labs and diagnostic centres in the national capital.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)